Marketing claims that ubiquinol represents a superior “active” form of CoQ10 are not supported by current bioavailability data, according to a comparative study by Lopez-Lluch et al. (Nutrition, 2019) examining different coenzyme Q10 formulations and their absorption rates.
CoQ10 Formulation Performance Varies by Manufacturing Process
Area under curve (AUC) comparison across seven different CoQ10 products
Source: Lopez-Lluch et al., Nutrition 2019; Mantle and Dybring analysis, Antioxidants 2020 | Georgian Medical Journal News
Body Efficiently Converts Between CoQ10 Forms
Coenzyme Q10 functions as a redox molecule that naturally cycles between its oxidized state (ubiquinone) and reduced state (ubiquinol) during cellular energy production. According to research published in Nutrition by Lopez-Lluch et al. (2019), enterocytes in the small intestine routinely reduce ubiquinone to ubiquinol during absorption.
The conversion process works bidirectionally. According to Lopez-Lluch et al. (Nutrition, 2019), when ubiquinol supplements are consumed, some oxidizes back to ubiquinone before reaching the intestine due to ubiquinol’s inherent instability in oxygen-rich environments. Despite these transformations, 95-98% of circulating CoQ10 maintains the ubiquinol form regardless of initial supplement type.
Bioavailability Depends on Manufacturing, Not Molecular Form
A crossover study by Lopez-Lluch et al. in Nutrition (2019) tested seven different CoQ10 formulations in 14 healthy adults, revealing 10-fold variation in area under the curve (AUC) values across products. The analysis by Mantle and Dybring in Antioxidants (2020) identified crystal dispersion as the key determinant of bioavailability.
According to Mantle and Dybring (Antioxidants, 2020), crystal-dispersed ubiquinone demonstrated approximately double the AUC compared to ubiquinol in soft gel formulations. Standard ubiquinone without crystal dispersion showed the lowest bioavailability, while ubiquinol occupied an intermediate position. These findings from Lopez-Lluch et al. (2019) indicate that manufacturing processes, particularly crystal lattice disruption to improve gastrointestinal fluid solubility, matter more than molecular oxidation state.
Clinical Outcomes Show Equivalent Therapeutic Effects
The Q-SYMBIO study, published in JACC Heart Failure by Mortensen et al. (2014), showed significant improvement in heart failure outcomes using ubiquinone supplementation. Research by Alehagen et al. (2013) demonstrated reduced cardiovascular mortality in elderly participants receiving ubiquinone.
Crystal-dispersed ubiquinone achieved roughly double the bioavailability compared to ubiquinol soft gel formulations, with the ‘premium’ ubiquinol form performing at intermediate levels.
— David Mantle and Alf Dybring, Antioxidants, 2020
Key takeaways
- Body efficiently converts between ubiquinone and ubiquinol forms with 95-98% circulating CoQ10 existing as ubiquinol regardless of supplement type (Lopez-Lluch et al., 2019)
- Crystal dispersion manufacturing process doubles bioavailability compared to standard formulations, outperforming ubiquinol soft gels (Mantle and Dybring, 2020)
- Clinical trials show equivalent therapeutic outcomes for both molecular forms when properly formulated (Mortensen et al., 2014; Alehagen et al., 2013)
Frequently asked questions
Does the body struggle to convert ubiquinone to ubiquinol?
No, according to Lopez-Lluch et al. (Nutrition, 2019), healthy adults efficiently convert between these forms throughout life. The conversion occurs naturally in enterocytes during absorption and continuously in cellular metabolism.
Why do some CoQ10 supplements show better absorption than others?
According to Mantle and Dybring (Antioxidants, 2020), manufacturing processes, particularly crystal dispersion, determine bioavailability more than molecular form. Crystal-dispersed formulations dissolve better in gastrointestinal fluids, improving absorption rates.
Are there clinical differences between ubiquinone and ubiquinol supplements?
Major cardiovascular trials by Mortensen et al. (2014) and Alehagen et al. (2013) demonstrate equivalent therapeutic effects for both forms when properly formulated.
Source: Ubiquinol is marketed as the “active” form of CoQ10
Was this article helpful?
Disclaimer. This article is health journalism intended for general information and education. It is not medical advice and is not a substitute for professional diagnosis or treatment. Always consult a qualified healthcare provider about your individual circumstances. Full disclaimer →
Related Coverage
Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD. Spotted an error? Contact the editorial team.
